These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 18074520)

  • 1. [Classification criteria for severity of adverse drug reactions].
    Hashiguchi M; Mochizuki M
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():73-80. PubMed ID: 18074520
    [No Abstract]   [Full Text] [Related]  

  • 2. [Classification and profile of adverse drug effects].
    Cordonnier M
    Bull Soc Belge Ophtalmol; 2007; (304):15-6. PubMed ID: 17718223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. European commission consultation on pharmacovigilance.
    Waller P; Beard K; Egberts T; Evans S; Hallas J; Hasford J; Laporte JR; Moore N; Shakir S; Sturkenboom M
    Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):108-9. PubMed ID: 18058839
    [No Abstract]   [Full Text] [Related]  

  • 4. How should we react to adverse drug reactions?
    Ferner RE; Beard K
    Postgrad Med J; 2011 Feb; 87(1024):81-2. PubMed ID: 21303818
    [No Abstract]   [Full Text] [Related]  

  • 5. Improving the reporting of adverse drug reactions in the hospital setting.
    Pushkin R; Frassetto L; Tsourounis C; Segal ES; Kim S
    Postgrad Med; 2010 Nov; 122(6):154-64. PubMed ID: 21084792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FDA attempting to overcome major roadblocks in monitoring drug safety.
    Zielinski SL
    J Natl Cancer Inst; 2005 Jun; 97(12):872-3. PubMed ID: 15956645
    [No Abstract]   [Full Text] [Related]  

  • 7. Adverse drug reactions and avalanches: life at the edge of chaos.
    Frattarelli DA
    J Clin Pharmacol; 2005 Aug; 45(8):866-71. PubMed ID: 16027396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low quality of reporting adverse drug reactions in paediatric randomised controlled trials.
    de Vries TW; van Roon EN
    Arch Dis Child; 2010 Dec; 95(12):1023-6. PubMed ID: 20551194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality check of spontaneous adverse drug reaction reporting forms of different countries.
    Bandekar MS; Anwikar SR; Kshirsagar NA
    Pharmacoepidemiol Drug Saf; 2010 Nov; 19(11):1181-5. PubMed ID: 20845409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving pharmacovigilance in Europe.
    Moore N; Bégaud B
    BMJ; 2010 Apr; 340():c1694. PubMed ID: 20385717
    [No Abstract]   [Full Text] [Related]  

  • 11. Inter-rater reliability of a classification system for hospital adverse drug event reports.
    Haynes K; Hennessy S; Morales KH; Gibson GA; Barnhart C; Jaipaul CK; Linkin DR
    Clin Pharmacol Ther; 2008 Mar; 83(3):485-8. PubMed ID: 17713472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effective and safe drugs. A constant challenge].
    Scheler F
    Internist (Berl); 1995 May; 36(5):511-5. PubMed ID: 7601624
    [No Abstract]   [Full Text] [Related]  

  • 13. [Increased significance of adverse effects of drugs--a threat to the industry].
    Werkö L
    Lakartidningen; 2004 Dec; 101(50):4134-6. PubMed ID: 15631270
    [No Abstract]   [Full Text] [Related]  

  • 14. [The Medical Products Agency suggests improved drug safety follow-ups. New grasps of better knowledge and adverse effects reporting].
    Sjölin-Forsberg G; Lindeskog B; Lundqvist KM; Feltelius N; Alvan G
    Lakartidningen; 2007 Apr 18-24; 104(16):1226-9. PubMed ID: 17536352
    [No Abstract]   [Full Text] [Related]  

  • 15. Points to consider: the roles of surveillance and epidemiology in advancing drug safety.
    Edwards R; Faich G; Tilson H;
    Pharmacoepidemiol Drug Saf; 2005 Sep; 14(9):665-7. PubMed ID: 15719353
    [No Abstract]   [Full Text] [Related]  

  • 16. Data incompatibility of adverse event reports electronically submitted to the AERS database.
    Glass LM
    Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):212-3. PubMed ID: 18236510
    [No Abstract]   [Full Text] [Related]  

  • 17. Preventability and severity assessment in reporting adverse drug reactions.
    Hartwig SC; Siegel J; Schneider PJ
    Am J Hosp Pharm; 1992 Sep; 49(9):2229-32. PubMed ID: 1524068
    [No Abstract]   [Full Text] [Related]  

  • 18. Accelerating statistical research in drug safety.
    Bilker W; Gogolak V; Goldsmith D; Hauben M; Herrera G; Hochberg A; Jolley S; Kulldorff M; Madigan D; Nelson R; Shapiro A; Shmueli G
    Pharmacoepidemiol Drug Saf; 2006 Sep; 15(9):687-8. PubMed ID: 16941519
    [No Abstract]   [Full Text] [Related]  

  • 19. [Adverse health effect relief services].
    Sato J; Miyazaki S
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():81-6. PubMed ID: 18074521
    [No Abstract]   [Full Text] [Related]  

  • 20. [Classification and mechanism of adverse drug reaction].
    Shimizu T; Ikeda Y
    Nihon Rinsho; 2007 Oct; 65 Suppl 8():5-9. PubMed ID: 18074508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.